Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway

<div>EGCG alleviated the degree of gastric mucosal lesions. (a) The rat gastric tissue was collected, and the pathological changes were observed after the H&amp;E staining. Bar = 100 <i>μ</i>m. (b) The establishment of the PLGC model and the effect of EGCG on the gastric mucosa of PLGC rats were further evaluated by AB-PAS staining. Bar = 100 <i>μ</i>m.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway 